Despite the benefits, there are challenges in simplifying regimens. These include the potential for reduced efficacy, the risk of drug interactions, and the need for robust clinical trials to ensure safety. Additionally, the cost of developing and manufacturing simplified medications can be high, which may limit accessibility, especially in low-income countries.
